Piekļūstamība
Aizvērt
Font size
100%
150%
200%
Contrast
Kontrasts 1
Kontrasts 1
Kontrasts 1
Kontrasts 1
Menu Menu
aizvērt

Swiss–Latvian Cooperation Programme moves from development to implementation of solutions to strengthen paediatric cancer care

On 1 October, the second Steering Committee meeting of the Swiss–Latvian Cooperation Programme “Advancement of Paediatric Cancer Care in Latvia” was held to review progress to date and agree on the next steps. Over the past two years, significant progress has been made in developing paediatric oncology diagnostics, treatment and long-term follow-up at the Children’s Clinical University Hospital (CCUH), as well as in strengthening laboratory capacity and international cooperation. The next phase will focus on integrating the solutions developed into routine clinical practice.

 

Representatives of the Embassy of the Swiss Confederation, the Ministry of Finance, Riga Stradiņš University, the Ministry of Health and CCUH reviewed the progress of the Programme, results achieved to date, the implementation of funding and procurement activities, as well as upcoming activities and challenges related to the Programme’s implementation.

Strengthening diagnostics, treatment and long-term patient follow-up

In the less than two years since the Programme began, one of its key achievements has been the targeted development of paediatric oncology care across several interconnected areas. The Programme has established the foundations for more advanced diagnostics and treatment, strengthened international cooperation and initiated the implementation of patient-centred solutions.

 

Significant investments are already being made in the modernisation, automation and digitalisation of the CCUH pathology and molecular diagnostics laboratories. Procurement procedures for laboratory equipment have been launched, including equipment for the introduction of next-generation sequencing technologies, and specialist training is under way.

 

At the same time, work continues on establishing the CCUH biobank. A biobank strategy has been developed and its implementation model agreed. The biobank will be an important resource for research and the development of new diagnostic and treatment solutions, as well as for the long-term use of stored biological samples and associated data.

 

Another important area of the Programme is the introduction of international expertise and treatment standards in Latvia. CCUH specialists are involved in the implementation of international treatment protocols, while multidisciplinary tumour boards for children with cancer, as well as inter-hospital tumour boards, are supporting the quality of care.

 

International cooperation is also being developed with Swiss healthcare and research institutions. A cooperation agreement has been signed between CCUH and Lausanne University Hospital (CHUV), providing a foundation for regular professional exchanges, expert consultations, training and other joint activities.

 

Greater focus on how children feel after treatment

The Programme is placing increasing emphasis on children’s quality of life and long-term health. A Clinical Trials Unit (CTU) has been established at the Children’s Hospital to support a more structured approach to conducting clinical trials.

 

As part of a pilot project in paediatric haemato-oncology, the patient-reported outcome measures (PROMs) approach has been introduced in Latvia for the first time. PROMs enable the systematic assessment of how a disease, its treatment and care affect a child’s quality of life. A long-term follow-up team has also been established, and educational materials for families have been adapted.

 

Next step – integrating solutions into routine care

In the next phase of the Programme, the main focus will be on ensuring that the solutions developed and piloted to date become a sustainable part of routine clinical practice.

 

In the coming months, procurement of laboratory equipment will continue, along with work on introducing new diagnostic methods.

 

In the first quarter of 2027, CCUH plans to launch the minimum operational activities of the biobank, as well as a full-scale long-term follow-up programme. The use of electronic PROM questionnaires will also be expanded for both inpatients and outpatients. Further work will be needed to establish a molecular genetics team and strengthen digital infrastructure and data management.

 

In the area of treatment, the Interfant-21 protocol is planned to be introduced in 2027. In cooperation with Swiss partners, regular professional exchange visits, expert involvement and training will also be developed to ensure that international experience is used as effectively as possible to advance paediatric oncology care in Latvia.

 

The “Advancement of Paediatric Cancer Care in Latvia” Programme is implemented with Swiss financial support. Its aim is to improve diagnostics, treatment and quality of life for children living with cancer or rare diseases, as well as to ensure continuous, patient-centred care.